Human Papillomavirus–Associated Anogenital Pathology in Females With HPV‐Positive Oropharyngeal Squamous Cell Carcinoma. (14th July 2020)

• Record Type: Journal Article
• Authors: Larish, Alyssa; Yin, Linda; Glaser, Gretchen; Moore, Eric; Bakkum‐Gamez, Jamie; Routman, David; Ma, Daniel; Price, Daniel; Janus, Jeffrey; Price, Katharine; Chintakuntlawar, Ashish; Neben‐Wittich, Michelle; Foote, Robert; Van Abel, Kathryn
• Is Part Of: Otolaryngology--head and neck surgery. Volume 164:Number 2(2021)
• Page Start: 369
• Page End: 374
• Publication Date: 2020-07-14
• Subjects: oropharyngeal carcinoma -- anogenital carcinoma and disease -- human papillomavirus; Head -- Surgery -- Periodicals; Neck -- Surgery -- Periodicals; Otolaryngology -- Periodicals; 617.51
• DOI: 10.1177/0194599820941499
• Languages: English
• ISSNs: 0194-5998

Abstract

Abstract : We sought to determine the incidence and location of human papillomavirus (HPV)–associated anogenital disease in women with HPV‐positive oropharyngeal squamous cell carcinoma (OPSCC) via a retrospective cohort study with prospective contact to update history at Mayo Clinic in Rochester, Minnesota. Females undergoing treatment for nonmetastatic HPV‐positive OPSCC from 2011 to 2019 were identified. Clinical history and outcomes were abstracted from medical records. Patients without documented anogenital history were contacted, consented, and administered a survey, and external records were requested and reviewed. Seventeen of 46 patients (37.0%) had a history of anogenital HPV‐associated disease, and 16 of 17 (94.1%) required procedures to diagnose or treat HPV lesions. The cervix was the most common site (16/17, 94.1%). Procedures included colposcopy (n = 6), cervical excision (n = 3), cryotherapy (n = 4), and hysterectomy (n = 3). One case of fatal cervical carcinoma was noted, diagnosed 1 year following OPSCC. Three of 17 (17.6%) had HPV‐related vulvovaginal disease, and 1 of 17 had anal disease. Patients with a history of HPV‐positive OPSCC may be at elevated risk for HPV‐associated anogenital disease.